Organogenesis

Vice President of R&D at Organogenesis, Katie Mowry Ph.D., shared insights in Clinical Leader around the importance of designing clinical trials around patients' real-world outcomes and experiences. Read the full article to discover how focusing on the lived experiences of patients impacted by knee osteoarthritis (OA) can help bring forth innovative treatment options. https://lnkd.in/eZxq6Zwr

Need to heal VLUs and DFUs faster? Bioengineered with living cells to transform wounds from chronic to acute, Apligraf is a skin substitute that’s backed by unmatched evidence in both VLUs and DFUs. Discover Apligraf: https://lnkd.in/dsrhZBqY

We were proud to support the Regenerative Medicine Forum at The Warren Alpert Medical School of Brown University, which brought together leaders from across Rhode Island’s life sciences ecosystem. The conversation underscored what we’ve been seeing in the environment: regenerative medicine is rapidly advancing from research into real-world clinical application. This event highlighted the critical role of collaboration across research, clinical care, and industry in accelerating progress for the field. At Organogenesis, we’re focused on translating these advances into therapies that improve healing and patient outcomes. Rhode Island is a place where this work can grow, and we’re excited to be part of that momentum. A special thank you to RI Life Science Hub for hosting such an impactful forum. #RegenerativeMedicine #Biotech #HealthcareInnovation

Meet AmchoThick: Amnion-Chorion-Amnion Allograft which may be used as a protective barrier for head-to-toe, partial- and full-thickness acute and chronic wounds. Learn more about AmchoThick: https://lnkd.in/eSfisEDB #WoundsCantWait #WoundCare #AmchoThick

Join our mission to advance healing and recovery beyond expectations.   We’re seeking distributors to expand their portfolio with cellular tissue-based skin substitute products- including antimicrobial extracellular matrix, collagen powder, and placental allografts.   If you are interested in learning more information about this opportunity, fill out this form today: https://lnkd.in/eGUJvcF2

Curious how Apligraf works?   Learn more about the mechanism of action behind Apligraf and how it helps heal VLUs and DFUs faster: https://lnkd.in/efR6GRcy

Good people, great conversations, that's a wrap on #DLS2026! Shoutout to our team for representing Organogenesis in Washington, D.C. Lloyd Burke Donald Mrdjenovich DPM CWS FACCWS BCMAS Yeabsera Tamire #DLS2026 #WoundCare #WoundsCantWait

That's a wrap on SAWC Spring 2026! Thank you to everyone who stopped by our booth in Charlotte. It was a great few days connecting with wound care professionals and sharing the latest from Organogenesis. organogenesis.com #SAWC2026 #WoundCare

In a changing market, one thing remains consistent. Connect with us at SAWC Booth #1308 to discuss the 20+ years of real-world evidence Apligraf has to offer. Not at SAWC Spring? Learn more today: Apligraf.com #WoundCare #RegenerativeMedicine  #WoundsCantWait  #SAWCSpring

The prospective, multi-center, randomized controlled trial evaluating the safety and efficacy of PuraPly® AM plus SOC achieved its primary endpoint. These findings underscore its role in supporting improved healing outcomes and advancing standards of care. Learn more: https://lnkd.in/e8JWnbKT